Dogwood Therapeutics, Inc.
DWTX
$6.21
-$0.01-0.16%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -38.20M | -24.74M | -21.98M | -12.35M | -5.73M |
| Total Depreciation and Amortization | 63.80K | 46.50K | 29.20K | 12.20K | -- |
| Total Amortization of Deferred Charges | 110.80K | 110.80K | 110.80K | 58.40K | -- |
| Total Other Non-Cash Items | 22.26M | 10.26M | 10.35M | 4.07M | 530.50K |
| Change in Net Operating Assets | -2.34M | -1.42M | -1.04M | -581.30K | 1.07M |
| Cash from Operations | -18.11M | -15.75M | -12.54M | -8.79M | -4.13M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 3.76M | 3.76M | 3.76M | 3.76M | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 3.76M | 3.76M | 3.76M | 3.76M | -- |
| Total Debt Issued | 18.32M | 18.32M | 18.32M | 15.32M | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 4.37M | 4.37M | 5.82M | 1.45M | 1.45M |
| Repurchase of Common Stock | -120.50K | -190.70K | -70.60K | -70.60K | -70.20K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 22.57M | 22.50M | 24.08M | 16.70M | 1.38M |
| Foreign Exchange rate Adjustments | -136.60K | -133.30K | -143.40K | -144.60K | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 8.09M | 10.38M | 15.16M | 11.53M | -2.75M |